PARATHYROID HORMONE RECEPTOR MEDIATES THE ANTI-MYELOMA EFFECT OF PROTEASOME INHIBITORS

Clinically significant serum parathyroid hormone (PTH) variations have been reported in multiple myeloma (MM) patients treated with proteasome inhibitors. To elucidate the association between serum PTH variations and proteasome inhibition in MM, the effect of PTH and PTHR1 ligands on the proteasome...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Zangari, Maurizio, Berno, Tamara, Yang, Ye, Zeng, Ming, Xu, Hongwei, Pappas, Lisa, Tricot, Guido, Kamalakar, Archana, Yoon, Donghoon, Suva, Larry J.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3967551/
https://ncbi.nlm.nih.gov/pubmed/24389365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2013.12.025
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items